The 2021 European Group on Graves’ Orbitopathy (EUGOGO) Clinical Practice Guidelines for the Medical Management of Graves’ Orbitopathy. Bartalena L, et al. https://pubmed.ncbi.nlm.nih.gov/34297684/. Date Accessed: February 19, 2026.
Update on the Surgical Management of Graves’ Orbitopathy. Frontiers in Endocrinology. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1080204/full. Date Accessed: February 19, 2026.
Nonsurgical Management of Upper Eyelid Retraction in Thyroid Eye Disease. Young S, et al. https://journals.lww.com/tjop/fulltext/2024/14040/nonsurgical_management_of_upper_eyelid_retraction_in.11.aspx. Date Accessed: February 19, 2026.
Management of Graves’ Upper Eyelid Retraction (GUER): A Review. Indian Journal of Ophthalmology. https://pmc.ncbi.nlm.nih.gov/articles/PMC11991553/. Date Accessed: February 19, 2026.
Triamcinolone Acetonide and Botulinum Toxin A for Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy. Huang X, et al. https://www.nature.com/articles/s41598-025-89063-4. Date Accessed: February 19, 2026.